Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eli Lilly's necitumumab improves OS in Phase III study
Eli Lilly's necitumumab improves OS in Phase III study
Eli Lilly's necitumumab improves OS in Phase III study
Submitted by
admin
on May 15, 2014 - 8:26am
Source:
The Fly on the Wall
News Tags:
Eli Lilly
necitumumab
non-small cell lung cancer
Headline:
Eli Lilly's necitumumab improves OS in Phase III study
Do Not Allow Advertisers to Use My Personal information
